Utilization of different anti-viral mechanisms by mammalian embryonic stem cells and differentiated cells

Immunology and Cell Biology

Volumn 95, Issue 1, 2017, Pages 17-23

  Guo, Yan Lin ^a  

^a The University of Southern Mississippi   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; ANTIVIRUS AGENT;

CELL DIFFERENTIATION; EMBRYO; EMBRYONIC STEM CELL; EUKARYOTE; HUMAN; HUMAN EMBRYONIC STEM CELL; INNATE IMMUNITY; MAMMAL CELL; MOUSE EMBRYONIC STEM CELL; NONHUMAN; PLURIPOTENT STEM CELL; PROTEIN EXPRESSION; REVIEW; RNA INTERFERENCE; SOMATIC CELL; VIRUS IMMUNITY; VIRUS INFECTION; ANIMAL; CYTOLOGY; MAMMAL; METABOLISM; VIROLOGY;

ANIMALS; ANTIVIRAL AGENTS; CELL DIFFERENTIATION; EMBRYONIC STEM CELLS; HUMANS; IMMUNITY, INNATE; MAMMALS; RNA INTERFERENCE;

EID: 84983567737     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2016.70     Document Type: Review

References (62)

1. Carthew RW, Sontheimer EJ. Origins and mechanisms of miRNAs and siRNAs. Cell 136: 642-655.
2. Samuel CE. Antiviral actions of interferons. Clin Microbiol Rev 2001; 14: 778-809.
3. Boehm T. Evolution of vertebrate immunity. Curr Biol 2012; 22: R722-R732.
4. Pare JM, Sullivan CS. Distinct antiviral responses in pluripotent versus differentiated cells. PLoS Pathog 2014; 10: e1003865.
5. Cullen BR, Cherry S, tenOever BR. Is RNA interference a physiologically relevant innate antiviral immune response in mammals? Cell Host Microbe 2013; 14: 374-378.
6. Jeang KT. RNAi in the regulation of mammalian viral infections. BMC Biol 2012; 10: 58.
7. Backes S, Langlois R, Schmid S, Varble A, Shim J, Sachs D et al. The mammalian response to virus infection is independent of small RNA silencing. Cell Rep 2014; 8: 114-125.
8. Maillard PV, Ciaudo C, Marchais A, Li Y, Jay F, Ding SW et al. Antiviral RNA interference in mammalian cells. Science 2013; 342: 235-238.
9. Li Y, Lu J, Han Y, Fan X, Ding SW. RNA interference functions as an antiviral immunity mechanism in mammals. Science 2013; 342: 231-234.
10. Wobus AM, Boheler KR. Embryonic stem cells: prospects for developmental biology and cell therapy. Physiol Rev 2005; 85: 635-678.
11. Keller G. Embryonic stem cell differentiation: emergence of a new era in biology and medicine. Genes Dev 2005; 19: 1129-1155.
12. Tabar V, Studer L. Pluripotent stem cells in regenerative medicine: challenges and recent progress. Nat Rev Genet 2014; 15: 82-92.
13. Stadtfeld M, Hochedlinger K. Induced pluripotency: history, mechanisms, and applications. Gene Dev 2010; 24: 2239-2263.
14. Guo YL, Carmichael GG, Wang R, Hong X, Acharya D, Huang F et al. Concise reviews: attenuated innate immunity in embryonic stem cells and its implications in developmental biology and regenerative medicine. Stem Cells 2015; 33: 3165-3173.
15. Swartzendruber DE, Lehman JM. Neoplastic differentiation: interaction of simian virus 40 and polyoma virus with murine teratocarcinoma cells in vitro. J Cell Physiol 1975; 85: 179-187.
16. Swartzendruber DE, Friedrich TD, Lehman JM. Resistance of teratocarcinoma stem cells to infection with simian virus 40: early events. J Cell Physiol 1977; 93: 25-30.
17. Burke DC, Graham CF, Lehman JM. Appearance of interferon inducibility and sensitivity during differentiation of murine teratocarcinoma cells in vitro. Cell 1978; 13: 243-248.
18. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998; 391: 806-811.
19. Cullen BR. Viruses and RNA interference: issues and controversies. J Virol 2014; 88: 12934-12936.
20. Sen GC. Virues and infections. Annu Rev Microbiol 2001; 55: 255-281.
21. Kumar H, Kawai T, Akira S. Toll-like receptors and innate immunity. Biochem Biophys Res Commun 2009; 388: 621-625.
22. Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 2011; 34: 637-650.
23. Yoneyama M, Kikuchi M, Natsukawa T, Shinobu N, Imaizumi T, Miyagishi M et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 2004; 5: 730-737.
24. Xiao TS, Fitzgerald KA. The cGAS-STING pathway for DNA sensing. Mol Cell 2013; 51: 135-139.
25. Ma Z, Damania B. The cGAS-STING defense pathway and its counteraction by viruses. Cell Host Microbe 2016; 19: 150-158.
26. Kato H, Takahasi K, Fujita T. RIG-I-like receptors: cytoplasmic sensors for non-self RNA. Immunol Rev 2011; 243: 91-98.
27. Stetson DB, Medzhitov R. Type I interferons in host defense. Immunity 2006; 25: 373-381.
28. Schroder K, Hertzog PJ, Ravasi T, Hume DA. Interferon-?: an overview of signals, mechanisms and functions. J Leukocyte Biol 2004; 75: 163-189.
29. Schoggins JW, Wilson SJ, Panis M, Murphy MY, Jones CT, Bieniasz P et al. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 2011; 472: 481-485.
30. Yan N, Chen ZJ. Intrinsic antiviral immunity. Nat Immunol 2012; 13: 214-222.
31. Bieniasz PD. Intrinsic immunity: a front-line defense against viral attack. Nat Immunol 2004; 5: 1109-1115.
32. Chakrabarti A, Jha BK, Silverman RH. New insights into the role of rnase l in innate immunity. J Interferon Cytokine Res 2011; 31: 49-57.
33. Garcia MA, Meurs EF, Esteban M. The dsRNA protein kinase PKR: virus and cell control. Biochimie 2007; 89: 799-811.
34. Bogerd HP, Skalsky RL, Kennedy EM, Furuse Y, Whisnant AW, Flores O et al. replication of many human viruses is refractory to inhibition by endogenous cellular microRNAs. J Virol 2014; 88: 8065-8076.
35. Kim VN, Han J, Siomi MC. Biogenesis of small RNAs in animals. Nat Rev Mol Cell Biol 2009; 10: 126-139.
36. Liu J, Carmell MA, Rivas FV, Marsden CG, Thomson JM, Song JJ et al. Argonaute2 is the catalytic engine of mammalian RNAi. Science 2004; 305: 1437-1441.
37. Seo GJ, Kincaid RP, Phanaksri T, Burke JM, Pare JM, Cox JE et al. Reciprocal inhibition between intracellular antiviral signaling and the RNAi machinery in mammalian cells. Cell Host Microbe 2013; 14: 10.
38. Ma E, MacRae IJ, Kirsch JF, Doudna JA. Autoinhibition of human dicer by its internal helicase domain. J Mol Biol 2008; 380: 237-243.
39. Yang S, Tutton S, Pierce E, Yoon K. Specific double-stranded RNA interference in undifferentiated mouse embryonic stem cells. Mol Cell Biol 2001; 21: 7807-7816.
40. Rajan R, Ye J, Bai S, Huang F, Guo YL. NF-?B, but not p38 MAP kinase, is required for TNF-?-induced expression of cell adhesion molecules in endothelial cells. J Cell Biochem 2008; 105: 477-486.
41. Foldes G, Liu A, Badiger R, Paul-Clark M, Moreno L, Lendvai Z et al. innate immunity in human embryonic stem cells: comparison with adult human endothelial cells. PLoS ONE 2010; 5: e10501.
42. Zampetaki A, Xiao Q, Zeng L, Hu Y, Xu Q. TLR4 expression in mouse embryonic stem cells and in stem cell-derived vascular cells is regulated by epigenetic modifications. Biochem Biophys Res Commun 2006; 347: 89-99.
43. Sidney LE, Kirkham GR, Buttery LD. Comparison of osteogenic differentiation of embryonic stem cells and primary osteoblasts revealed by responses to IL-1beta, TNF-alpha, and IFN-gamma. Stem Cells Dev 2014; 23: 605-617.
44. Yu J, Rossi R, Hale C, Goulding D, Dougan G. Interaction of enteric bacterial pathogens with murine embryonic stem cells. Infect Immunity 2009; 77: 585-597.
45. Taylor T, Kim YJ, Ou X, Derbigny W, Broxmeyer HE. Toll-like receptor 2 mediates proliferation, survival, NF-kappaB translocation, and cytokine mRNA expression in LIF-maintained mouse embryonic stem cells. Stem Cells Dev 2010; 19: 1333-1341.
46. Chen LL, Yang L, Carmichael GG. Molecular basis for an attenuated cytoplasmic dsRNA response in human embryonic stem cells. Cell cycle 2010; 9: 3552-3564.
47. Freudenberg MA, Tchaptchet S, Keck S, Fejer Gr, Huber M, Schutze N et al. Lipopolysaccharide sensing an important factor in the innate immune response to Gram-negative bacterial infections: benefits and hazards of LPS hypersensitivity. Immunobiol 2008; 213: 193-203.
48. Matsumoto M, Seya T. TLR3: interferon induction by double-stranded RNA including poly(I:C). Adv Drug Deliv Rev 2008; 60: 805-812.
49. Wash R, Calabressi S, Franz S, Griffiths SJ, Goulding D, Tan E-P et al. Permissive and restricted virus infection of murine embryonic stem cells. J Gen Virol 2012; 93: 2118-2130.
50. Chen GY, Hwang SM, Su HJ, Kuo CY, Luo WY, Lo KW et al. Defective antiviral responses of induced pluripotent stem cells to baculoviral vector transduction. J Virol 2012; 86: 8041-8049.
51. D'Angelo W, Acharya D, Wang R, Wang J, Gurung C, Chen B et al. Development of antiviral innate immunity during in vitro differentiation of mouse embryonic stem cells. Stem Cells Dev 2016; 25: 648-659.
52. Wang R, Wang J, Paul AM, Acharya D, Bai F, Huang F et al. Mouse embryonic stem cells are deficient in type I interferon expression in response to viral infections and double-stranded RNA. J Biol Chem 2013; 288: 15926-15936.
53. Wang R, Wang J, Acharya D, Paul AM, Bai F, Huang F et al. Antiviral responses in mouse embryonic stem cells: differential development of cellular mechanisms in type I interferon production and response. J Biol Chem 2014; 289: 25186-25198.
54. Hong XX, Carmichael GG. Innate immunity in pluripotent human cells: attenuated response to interferon-?. J Biol Chem 2013; 288: 16196-16205.
55. Whyatt LM, Duwel A, Smith AG, Rathjen PD. The responsiveness of embryonic stem cells to alpha and beta interferons provides the basis of an inducible expression system for analysis of developmental control genes. Mol Cell Biol 1993; 13: 7971-7976.
56. Ruffner H, Reis LF, Naf D, Weissmann C. Induction of type I interferon genes and interferon-inducible genes in embryonal stem cells devoid of interferon regulatory factor 1. Proc Natl Acad Sci USA 1993; 90: 11503-11507.
57. Levy O. Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat Rev Immunol 2007; 7: 379-390.
58. Hertzog PJ, Hwang SY, Kola I. Role of interferons in the regulation of cell proliferation, differentiation, and development. Mol Reprod Dev 1994; 39: 226-232.
59. Wang R, Teng C, Spangler J, Wang J, Huang F, Guo Y-L. Mouse embryonic stem cells have underdeveloped antiviral mechanisms that can be exploited for the development of mRNA-mediated gene expression strategy. Stem Cells Dev 2014; 23: 594-604.
60. Baeuerle PA, Henkel T. Function and activation of NF-kappaB in the immune system. Annu Rev Immunol 1994; 12: 141-179.
61. Hayden MS, Ghosh S. NF-kB, the first quarter-century: remarkable progress and outstanding questions. Gene Dev 2012; 26: 203-234.
62. Kim YE, Kang HB, Park JA, Nam KH, Kwon HJ, Lee Y. Upregulation of NF-kappaB upon differentiation of mouse embryonic stem cells. BMB Rep 2008; 41: 705-709.